Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study

<div>The number of patients who were maintained on different cumulative sacubitril/valsartan doses: 24 patients received 50 mg, 45 patients 100 mg, 117 patients 200 mg, and 4 patients 400 mg daily.</div>

Journal of the Renin-Angiotensin-Aldosterone System

fig4

Figure 4

Figure 4: Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study 

Figure 4 | Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study 